The problem is that lean mass alone cannot answer the clinical question we actually care about : Is the patient becoming weaker, less functional, poorly nourished, dehydrated, or less physically capable
Medical evidence and documentation will be crucial in establishing a connection between your symptoms and the medication
Mounjaro is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, whilst Lantus is a long-acting basal insulin analogue
To view or add a comment, sign in The FDA announced nine voucher recipients under the new Commissioners National Priority Voucher (CNPV) pilot program
Higher doses resulted in greater reductions of liver fat and improvements in biomarkers such as insulin, C-peptide, leptin, and adiponectin